Guidant Cites Ethics In Countering Drug-Eluting Stent Data Enjoinment
This article was originally published in The Gray Sheet
Guidant is relying on two ethical arguments to persuade a federal judge not to block access to clinical drug-eluting stent data collected in collaboration with Cook, Inc
You may also be interested in...
Guidant's $3 bil. purchase of Cook Group does not represent a "change of ownership" under the terms of a 1997 licensing agreement between subsidiary Cook, Inc., Angiotech Pharmaceuticals and Boston Scientific, Guidant asserts
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.